https://sputnikglobe.com/20211222/russian-health-ministry-registers-mir-19-drug-for-treatment-of-coronavirus-fmba-says-1091731290.html
Russian Health Ministry Registers MIR 19 Drug for Treatment of Coronavirus, FMBA Says
Russian Health Ministry Registers MIR 19 Drug for Treatment of Coronavirus, FMBA Says
Sputnik International
The Russian Health Ministry registered the MIR 19 drug for coronavirus treatment, developed at the Institute of Immunology of the Federal Biomedical Agency (FMBA), the FMBA said.
2021-12-22T18:49+0000
2021-12-22T18:49+0000
2021-12-22T18:49+0000
russian health ministry
russia
medications
coronavirus
covid-19
https://cdn1.img.sputnikglobe.com/img/07e5/0c/16/1091731003_0:84:829:550_1920x0_80_0_0_ba9ad7db2284991bf38aa48766f4bf9c.jpg
"The Russian Health Ministry has registered the MIR 19 drug for the treatment of the new coronavirus infection, developed on behalf of the head of the FMBA of Russia, Veronika Skvortsova, at the State Research Centre Immunology Institute of the FMBA of Russia", the statement says.The drug works at the gene level, namely, selectively suppressing the activity of the vital RNA sequences of the virus, while not affecting the human genome, according to the FMBA.The institute also noted that the medication, which is intended for inhalation use in a hospital setting, is "universal" against any coronavirus variants.The clinical trials of the drug have proven its safety and efficacy, the FMBA underlined. The drug does not affect the human body, only targeting the virus.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
institute of immunology of the federal biomedical agency, fmba, coronavirus treatment, coronavirus drug, covid-19 drug, mir-19, mir 19, mir 19 drug, are there any coronavirus drugs,
institute of immunology of the federal biomedical agency, fmba, coronavirus treatment, coronavirus drug, covid-19 drug, mir-19, mir 19, mir 19 drug, are there any coronavirus drugs,
Russian Health Ministry Registers MIR 19 Drug for Treatment of Coronavirus, FMBA Says
MOSCOW, (Sputnik) - The Russian Health Ministry has registered the MIR 19 drug for coronavirus treatment, developed at the Institute of Immunology of the Federal Biomedical Agency (FMBA), the FMBA said.
"The Russian Health Ministry has registered the MIR 19 drug for the treatment of the new coronavirus infection, developed on behalf of the head of the FMBA of Russia, Veronika Skvortsova, at the State Research Centre Immunology Institute of the FMBA of Russia", the statement says.
The drug works at the gene level, namely, selectively suppressing the activity of the vital RNA sequences of the virus, while not affecting the human genome, according to the FMBA.
The institute also noted that the medication, which is intended for inhalation use in a hospital setting, is "universal" against
any coronavirus variants.
The clinical trials of the drug have proven its safety and efficacy, the FMBA underlined. The drug does not affect the human body, only targeting the virus.
"In this regard, the development of adverse reactions in patients has not been detected", the press service specified.
